# LYTGOBI
> **NDA214801** · New Drug Application · Sponsor: TAIHO ONCOLOGY · Approved 2022-09-30
## Drug
- **FDA Application Number:** NDA214801
- **Application type:** New Drug Application
- **Brand name:** LYTGOBI
- **Generic name:** Futibatinib
- **Active ingredients:** FUTIBATINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAIHO ONCOLOGY
- **First approval:** 2022-09-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214801)
---
*AI Analytics · CC0 1.0*